2REL | Serine Protease Inhibitor | date | Apr 01, 1997 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
title | Solution Structure Of R-Elafin, A Specific Inhibitor Of Elas 11 Structures | ||||||||||
authors | C.Francart, M.Dauchez, A.J.P.Alix, G.Lippens | ||||||||||
compound | source | ||||||||||
Molecule: R-Elafin Chain: A Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 Other_details: The Polypeptide May Be Obtained By Expressio Plasmidic Expression Systems In Hosts Such As Escherichia C Yeast, The Polypeptide Being Also Obtainable From Psoriatic Patent Number 5,464,822 Date Of Patent Nov. 7, 1995 By Chri E., Wiedow O., Schroder J.M. The Protein Was Provided By Ze Pharmaceuticals. | ||||||||||
method | Solution NMR | ||||||||||
note | 2REL supersedes 1REL | ||||||||||
related structures | by homologous chain: 1FLE | ||||||||||
Gene Ontology |
| ||||||||||
Primary reference | Solution structure of R-elafin, a specific inhibitor of elastase., Francart C, Dauchez M, Alix AJ, Lippens G, J Mol Biol 1997 May 9;268(3):666-77. PMID:9171290 |
Data retrieval |
View 2REL in 3D |
Visual 3D analysis of 2REL |
Structure-derived information |
- Domain d2rel__, region [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 2REL |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |